CA
IBB icon

CoreCap Advisors’s iShares Biotechnology ETF IBB Stock Holding History

CoreCap Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Buy
1,874
+254
+16% +$43.7K 0.01% 660
2026
Q1 		$274K Sell
1,620
-1,027
-39% -$176K 0.01% 693
2025
Q4 		$447K Buy
2,647
+1,448
+121% +$235K 0.02% 536
2025
Q3 		$173K Sell
1,199
-112
-9% -$15.3K 0.01% 848
2025
Q2 		$166K Buy
1,311
+65
+5% +$7.98K 0.01% 802
2025
Q1 		$159K Buy
1,246
+67
+6% +$9.09K 0.01% 734
2024
Q4 		$156K Sell
1,179
-40
-3% -$5.62K 0.01% 775
2024
Q3 		$177K Buy
+1,219
New +$176K 0.01% 730
2024
Q2 		– Sell
-1,313
Closed -$180K – 2047
2024
Q1 		$180K Buy
+1,313
New +$179K 0.01% 659
2022
Q4 		$220K Buy
+1,679
New +$217K 0.02% 515
2022
Q3 		– Sell
-1,917
Closed -$226K – 1222
2022
Q2 		$226K Buy
1,917
+3
+0.2% +$356 0.02% 486
2022
Q1 		$250K Sell
1,914
-158
-8% -$20.6K 0.02% 452
2021
Q4 		$316K Buy
+2,072
New +$321K 0.02% 435

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

CoreCap Advisors's IBB Position: Q2 2026 in Review

CoreCap Advisors increased its iShares Biotechnology ETF (IBB) stake by 16% in Q2 2026, buying an estimated $43.7K and bringing the position to 1,874 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #660.

CoreCap Advisors first reported a position in IBB in Q4 2021 and has held it in 13 quarters since. The position peaked at $447K in Q4 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • CoreCap Advisors held 1,874 shares of iShares Biotechnology ETF worth $356K as of Q2 2026.
  • CoreCap Advisors bought 254 iShares Biotechnology ETF shares in Q2 2026, an estimated $43.7K.
  • iShares Biotechnology ETF made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #660 holding.
  • CoreCap Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's iShares Biotechnology ETF position peaked at $447K in Q4 2025.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.